ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JAMES BLACKWELL M.D.

Internal Medicine

19,295

$929K

822
759 are 65+

1%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

GANESH KINI MD

Internal Medicine

19,203

$1.53M

798
529 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$79
Average prescription price

Avg: $56

KENNETH GORDON MD

Internal Medicine

19,191

$842K

1057
728 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

DENNIS HARPER MD

Internal Medicine

19,174

$871K

482
309 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $56

CATHERINE MORRIS M.D.

Internal Medicine

19,169

$1.31M

905
814 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $56

HARVEY JONES M.D

Internal Medicine

18,949

$1.23M

640
287 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

34%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $56

ROBERT HALL M.D.

Internal Medicine

18,853

$816K

927
731 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $56

MICHAEL PEACOCK M.D.

Internal Medicine

18,841

$1.07M

362
279 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

25%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $56

STEVEN RIGDON MD

Internal Medicine

18,766

$877K

782
671 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $56

JOSEPH BAKER MD

Internal Medicine

18,709

$922K

662
500 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

KATHARINE AMMONS MD

Internal Medicine

18,701

$1.8M

625
397 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$96
Average prescription price

Avg: $56

AMIR USMAN MD

Internal Medicine

18,683

$694K

925
644 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $56

JAMES SMITH M.D.

Internal Medicine

18,640

$942K

737
666 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

NEIL GORDON M.D.

Internal Medicine

18,628

$687K

502
408 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

38%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $56

RAM PURI M.D.

Internal Medicine

18,388

$827K

503
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $56

PAUL HARVEY MD

Internal Medicine

18,352

$952K

678
470 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

JIN KIM M.D.

Internal Medicine

18,304

$1.68M

889
822 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 26%

$92
Average prescription price

Avg: $56

JESSE SCOTT M.D.

Internal Medicine

18,156

$901K

481
419 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

ELLIS MALONE MD

Internal Medicine

18,137

$718K

919
723 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

ALAN JUSTICE M.D.

Internal Medicine

18,063

$1.18M

773
644 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $56

T YATES MD

Internal Medicine

18,039

$1.18M

679
548 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $56

EVANGELOS MORAITIS M.D.

Internal Medicine

18,012

$892K

761
536 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

WILLIAM WEAVER M.D.

Internal Medicine

17,896

$1M

517
458 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $56

MOHAMMAD RAHMAN MD

Internal Medicine

17,881

$883K

490
301 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

FIRAS BANNOUT MD

Internal Medicine

17,880

$952K

530
321 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank